Scientists studying metformin say the generic drug slows the ‘burn rate’ in living cells in ways that increase longevity. […] Metformin, by contrast, has both an enviable safety profile and a decades-long history of human use, said Dr. Michael Pollak, director of cancer prevention in the department of oncology at McGill University. […] Read more
Category:
Published on: 9 Jul 2018
Metformin, the most widely used drug to treat type 2 diabetes, could potentially be used to treat symptoms of Fragile X syndrome, an inherited form of intellectual disability and a cause of some forms of autism.
A new study led by researchers at McGill University, the University of Edinburgh and Université de Montréal has found that metformin improves social, behavioural and morphological defects in Fragile X mice.
Category:
Published on: 15 May 2017
